Particle Therapy 2017

• In design-phase:

The

PC05 neoadjuvant protocol

(preopera3vely) for

pa3ents with resectable and marginally

resectable cancers.

Randomiza3on between:

–

59.40CGE to gross disease

–

50.40CGE to regional nodes with a gross disease

boost to 59.40CGE

•Proton therapy may allow for comprehensive elec3ve nodal coverage for pa3ents receiving

neoadjuvant radiotherapy for localized pancrea3c head cancers.

•Lee RY,

Nichols RC

Jr, Huh SN, Ho MW, Li Z, Zaiden R, Awad ZT, Ahmed B, Hoppe BS.

•J Gastrointest Oncol. 2013 Dec;4(4):374-9. doi: 10.3978/j.issn.2078-6891.2013.043.